-
Avextra AG Announces Closing of EU 17 Million Capital Raise
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022…
-
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Together these three partners will develop a pathway for the first cannabis inhalers to comply with European Medical Device Regulations…
-
Medical Device Submission for a Cannabis Extract Inhaler
Bensheim, Gemünden (Wohra) and Gauting, 09. November 2022 – Together these three partners will develop a pathway for the first cannabis inhalers to comply with European Medical Device Regulations…
-
Eurox has rebranded as Avextra
Bensheim, 14.9.2022 – Eurox has rebranded as Avextra. The leading manufacturer of cannabis-based medicines Made in Germany will premiere under its new name at the Expopharm Pharmacists’ Congress in Munich from September 14 to 17, 2022. The name Avextra emphasises the company’s clear focus on the highest quality cannabis extracts and its commitment to the […]
-
New board member at Eurox AG: Marla Luther is Chief Strategy Officer
Marla Luther is the new Chief Strategy Officer at Eurox Pharma, the leading European vertically-integrated manufacturer of cannabis-based medicines, which will operate under the Avextra name.
-
A syringe full of cannabis – FAZ
One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business accomplishments.
-
Good Business with Grass – Metropol April/May 2022
Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further legalization.
-
Eurox Group raises €4.4M at a significant premium enabling targeted investment – Portuguese Iberis Capital becomes a new institutional investor
As one of the leading European vertically-integrated companies developing and manufacturing cannabis based medicines, Eurox Group, based in Hesse, Germany, has successfully fundraised €4,4 Million from new and existing investors at an approximate 62% premium to its July 2021 fundraise.
-
5 years of cannabis-as-medicine law
Eurox Pharma prioritizes research and development. In collaboration with physicians, pharmacists and research, the company aims to produce evidence-based products that meet the specific needs of patients, rather than simply marketing another cannabis product as profitably as possible.
-
Top 16 cannabis startups set to take off in 2022, according to Business Insider
Last year was the year of megarounds for cannabis startups…